Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-14

FDA Approved: OFLOXACIN — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved the original application for OFLOXACIN OTIC from Lifestar Pharma LLC under ANDA 216130.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OFLOXACIN OTIC (ofloxacin)

Snippet

ORIG AP for OFLOXACIN (OFLOXACIN OTIC)